Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.

TSX:SVA - Post by User

Sernova Corp > Sernova Global Partnership Family Office Presentation

<< Previous

Bullboard Posts

Next >>

Comment by BioTeckon May 25, 2021 6:57pm

137 Views

Post# 33264968

RE:RE:RE:Sernova Global Partnership Family Office Presentation

Not sure I believe you hofbag. Not that you're lying but you don't understand the clinical trial protocol. The patient was only insulin free after a portal vein injection. Anyone who understands the trial a little better care to comment on the top up injections?

hoffbag wrote: Point 2 of your post is what I believe to be the critical remark of the presentation (also the new add on about Hemo).

Phil made a remark about 13:30 regarding "current" data (he has seen but isnt published) extending the insulin injection-free period of this subject beyond 6 months and declaring an "effective cure". This is HUGE to me and begs the question how others are doing.

To respond to your point 2 question, the islet injections refer to the first and second (topping up) injections of cells into the cell pouch (a booster so to speak). So insulin injection free was achieved after "top up" and the patient STILL remains free from having to inject insulin (time frame ? but guessing 6 months to a year).

Phil did speak well and seemed to be working to contain himself. My impression is that he seemed very keen to share.